← Mechanisms of action
SSTR2
SINGLE PROTEINHomo sapiens
Preferred name: Somatostatin receptor 2 ChEMBL ↗
Linked proteins
Drugs acting on this target (16)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 225ac-sso110 | Agonist | experimental | Peptide | SSTR2 agonist |
| lanreotide (somatuline depot) | Agonist | approved | Peptide | SSTR2 agonist |
| Paltusotine | Agonist | approved | Small molecule | Somatostatin receptor 2 agonist |
| pasireotide (signifor) | Agonist | approved | Peptide | SSTR2 agonist |
| vapreotidum | Agonist | experimental | Peptide | SSTR2 agonist |
| veldoreotide | Agonist | experimental | Peptide | Somatostatin receptor 2 agonist |
| al18f-nota-lm3 | Antagonist | experimental | Small molecule | SSTR2 antagonist |
| zt-01 | Antagonist | experimental | Small molecule | SSTR2 antagonist |
| in-111 dotatate | Binding agent | experimental | Peptide | SSTR2 binding agent |
| mb0151 | Inhibitor | experimental | Small molecule | SSTR2 inhibitor |
| pen-221 | Inhibitor | experimental | mAb | SSTR2 inhibitor |
| xmab18087 | Inhibitor | experimental | mAb | SSTR2 inhibitor |
| y90 edotreotide | Inhibitor | experimental | mAb | SSTR2 inhibitor |
| ryz401 | Radiodepletion | experimental | Small molecule | SSTR2 radiodepletion |
| 68ga-fl-031 | Radiopharmaceutical | experimental | Peptide | SSTR2 radiopharmaceutical |
| 68ga-tate-rgd | Radiopharmaceutical | experimental | Peptide | SSTR2 radiopharmaceutical |